These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32854292)

  • 1. Promoting
    Thomford NE; Mhandire D; Dandara C; Kyei GB
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32854292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
    Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
    J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and facilitators to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-Saharan Africa: A mixed-methods systematic review and meta-analysis.
    Hlophe LD; Tamuzi JL; Shumba CS; Nyasulu PS
    PLoS One; 2023; 18(5):e0276411. PubMed ID: 37200399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    Myer L; Phillips TK
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to and enablers of uptake of and adherence to antiretroviral therapy in the context of integrated HIV and tuberculosis treatment among adults in sub-Saharan Africa: a protocol for a systematic literature review.
    Momo Kadia B; Takah NF; Akem Dimala C; Smith A
    BMJ Open; 2019 Oct; 9(10):e031789. PubMed ID: 31662398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018.
    Lecher SL; Fonjungo P; Ellenberger D; Toure CA; Alemnji G; Bowen N; Basiye F; Beukes A; Carmona S; de Klerk M; Diallo K; Dziuban E; Kiyaga C; Mbah H; Mengistu J; Mots'oane T; Mwangi C; Mwangi JW; Mwasekaga M; N'tale J; Naluguza M; Ssewanyana I; Stevens W; Zungu I; Bhairavabhotla R; Chun H; Gaffga N; Jadczak S; Lloyd S; Nguyen S; Pati R; Sleeman K; Zeh C; Zhang G; Alexander H
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(21):775-778. PubMed ID: 34043612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States.
    Nyaku M; Beer L; Shu F
    AIDS Care; 2019 May; 31(5):599-608. PubMed ID: 30309269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors impacting antiretroviral therapy adherence among human immunodeficiency virus-positive adolescents in Sub-Saharan Africa: a systematic review.
    Ammon N; Mason S; Corkery JM
    Public Health; 2018 Apr; 157():20-31. PubMed ID: 29501984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new "test and treat" policy of the World Health Organization?
    Nansseu JR; Bigna JJ
    Infect Dis Poverty; 2017 Feb; 6(1):24. PubMed ID: 28196511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participatory Prototyping of a Tailored Undetectable Equals Untransmittable Message to Increase HIV Testing Among Men in Western Cape, South Africa.
    Smith PJ; Joseph Davey DL; Schmucker L; Bruns C; Bekker LG; Medina-Marino A; Thirumurthy H; Buttenheim AM
    AIDS Patient Care STDS; 2021 Nov; 35(11):428-434. PubMed ID: 34739334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda.
    Musinguzi N; Mocello RA; Boum Y; Hunt PW; Martin JN; Haberer JE; Bangsberg DR; Siedner MJ
    AIDS Behav; 2017 Jun; 21(6):1735-1740. PubMed ID: 27256394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship.
    Penot P; Héma A; Bado G; Sombié D; Kaboré FN; Poda A; Michon C; Terzolo O; Traoré A; Slama L; Sawadogo A; Laurent C
    AIDS Care; 2018 Dec; 30(12):1502-1506. PubMed ID: 29991274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
    Boender TS; Hamers RL; Ondoa P; Wellington M; Chimbetete C; Siwale M; Labib Maksimos EE; Balinda SN; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Stevens W; Rinke de Wit TF; Sigaloff KC
    J Infect Dis; 2016 Sep; 214(6):873-83. PubMed ID: 27402780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin Zymography.
    Platt MO; Evans D; Keegan PM; McNamara L; Parker IK; Roberts LM; Caulk AW; Gleason RL; Seifu D; Amogne W; Penny C
    Mol Biotechnol; 2016 Jan; 58(1):56-64. PubMed ID: 26589706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor adherence to antiretroviral therapy among adult people living with HIV initiated during the COVID-19 epidemic waves - observations at the University Teaching Hospital in Lusaka, Zambia.
    Kafwanka P; Nalule FM; Michelo C
    Front Public Health; 2023; 11():1094214. PubMed ID: 36992897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.
    Inzaule SC; Ondoa P; Peter T; Mugyenyi PN; Stevens WS; de Wit TFR; Hamers RL
    Lancet Infect Dis; 2016 Nov; 16(11):e267-e275. PubMed ID: 27569762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.